Glycaemic Control and Other Clinical Parameters in Adult Type 2 Diabetes Patients on Basal Insulin Initiating Treatment With IDegLira in Routine Clinical Practice in Colombia - A Single-arm, Non-interventional Retrospective Chart Review Study
Latest Information Update: 10 Nov 2022
At a glance
- Drugs Insulin degludec/liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SPIRIT
- Sponsors Novo Nordisk
Most Recent Events
- 04 Nov 2022 Status changed from not yet recruiting to completed.
- 18 Apr 2022 New trial record